OPINION

Patients Can't Wait for Federal Action on Knock-Off Medicines

Thursday, 09 October 2025 04:26 PM EDT

For millions of Americans, the new class of GLP-1 weight-loss drugs are as close to a miracle as modern medicine gets. Sold under brand names like Wegovy and Zepbound, these drugs have proven astoundingly successful at helping patients shed pounds.

Unfortunately, a number of unscrupulous companies have sought to capitalize on the growing demand for GLP-1s in ways putting patients at serious risk of harm. Many of these operations — including telehealth services and online pharmacies — are making their own unapproved versions of these medicines and leading patients to believe they're buying the genuine article…

Read full article on Newsmax.

https://www.newsmax.com/sallypipes/glp-fda-ozempic/2025/10/09/id/1229717/